Epidermolisis ampollar adquirida. Roberto Glorio · Authors. Roberto Glorio + 3 · Roberto Glorio. MARÍA JUAREZ. María Juárez. Alberto Woscoff. – Buy Recién nacido con Epidermolisis ampollar: Epidermólisis ampollar: Revisión bibliográfica, a propósito de un caso book online at best prices in. Recién nacido con Epidermolisis ampollar: Epidermólisis ampollar: Revisión bibliográfica, a propósito de un caso (Spanish Edition) [Marcela koroluk.

| Author: | Shazil Tauramar |
| Country: | Niger |
| Language: | English (Spanish) |
| Genre: | Education |
| Published (Last): | 8 December 2004 |
| Pages: | 492 |
| PDF File Size: | 6.40 Mb |
| ePub File Size: | 8.98 Mb |
| ISBN: | 795-2-48314-478-5 |
| Downloads: | 8598 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Malazahn |
Diagnostic methods Diagnosis relies on the results of histological analysis, indirect or direct immunofluorescence studies, immunoblotting and immune electron microscopy. During the disease course, the inflammatory forms may evolve to resemble the classical form and patients with the classical present with bursts of inflammatory disease. Specialised Social Services Eurordis directory. Involvement of the mucosae in particular the ampollat and ORL mucosal membranes is associated with more severe disease, which may lead to a poorer functional, or even vital, prognosis.
The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
Epidermolisis ampollar adquirida | Roberto Glorio –
Etiology EBA is caused by the production of antibodies against the skin basement membrane collagen VII, the major component of the anchoring fibrils located in the dermal-epidermal junction, under the lamina densa. EBA is caused by the production of antibodies against the skin basement membrane collagen VII, the major component of the anchoring fibrils located in the dermal-epidermal junction, under the lamina densa. Immunosuppresive therapy such as treatment with cyclosporine may by required in severe cases.

Diagnosis relies on the results of histological analysis, indirect or direct immunofluorescence studies, immunoblotting and immune electron microscopy. Lesions are usually triggered by minor trauma and are mainly localised to sites that are easily injured.
File:Tratamiento epidermolisis – Wikimedia Commons
The disease manifests in two clinical forms: Additional information Further information on this disease Epidermooisis s 1 Gene s 0 Clinical signs and symptoms Other website s 4. Involvement of the mucous membranes, hair and nails is frequent.
Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. Summary and related texts.
There was a problem providing the content you requested
Although further trials are necessary, encouraging results have been obtained with other approaches such as intravenous immunoglobulin therapy, extracorporeal photochemotherapy and, more recently, rituximab therapy.
Clinical description The disease manifests in two clinical forms: Other search option s Alphabetical list. Prognosis EBA is a chronic disease that resolves ampollaf and leads to dystrophic scarring and milia. The disease manifests during childhood. The nosological boundaries between EBA and bullous systemic lupus erythematosus see this term remain under debate.
Differential diagnosis The differential diagnosis should include other subepidermal, autoimmune bullous diseases.

Epidermolysis bullosa acquisita Prevalence: As in dystrophic HEB caused by mutations in the gene encoding collagen VII, the deposition of antibodies on collagen VII leads to cleavage between the epidermis and dermis below the lamina densa. The documents contained in this web site are presented for information purposes only. The first line treatment revolves around administration of dapsone or sulfasalazine.
File:Tratamiento epidermolisis bullosa.jpg
Only comments written in English can be processed. Epidermolysis bullosa acquisita EBA is a subepidermal bullous dermatosis of autoimmune origin that was named as a result of epidermoolisis resemblance to hereditary forms of epidermolysis bullosa HEBmost notably dystrophic HEB. Management and treatment The first line treatment revolves around administration of dapsone or sulfasalazine.
The inflammatory form was recognised more recently and resembles bullous pemphigoid see this term with bullae developing on erythematous skin lesions, plaques without bullous eruptions and diffuse lesions that are not limited to trauma-prone sites. Health care resources for this disease Expert centres Diagnostic tests 6 Patient organisations 8 Orphan drug s 1. In the classical form, onset occurs in adulthood and the bullae may be soft, tense or haemorrhagic, located on otherwise healthy skin.

Summary Epidemiology The prevalence is unknown but the incidence is estimated at 1 in 96, new cases per year. Check this box if you wish to receive a copy of your message.
EBA is a chronic disease ampolla resolves slowly and leads to dystrophic scarring and milia. Disease definition Epidermolysis bullosa acquisita EBA is a subepidermal bullous dermatosis of autoimmune origin that was named as a result of its resemblance to hereditary forms of epidermolysis bullosa HEBmost notably dystrophic HEB.
For all other comments, please send your remarks via contact us.
